Author/Authors :
Joseph Sang III, Charlie Department of Pediatrics - University of Alabama at Birmingham, Birmingham, AL, USA , Heindl, Brittain Department of Medicine - Division of Cardiovascular Disease - University of Alabama at Birmingham, Birmingham, AL, USA , Von Mering, Gregory Department of Medicine - Division of Cardiovascular Disease - University of Alabama at Birmingham, Birmingham, AL, USA , Brott, Brigitta Department of Medicine - Division of Cardiovascular Disease - University of Alabama at Birmingham, Birmingham, AL, USA , Kopf, Robert S. Department of Medicine - Division of Pulmonary Allergy and Critical Care Medicine - University of Alabama at Birmingham, Birmingham, AL, USA , Rajapreyar, Indranee Department of Medicine - Division of Cardiovascular Disease - University of Alabama at Birmingham, Birmingham, AL, USA
Abstract :
Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique
challenges in approaching patients with acute ST-segment changes. We describe two distinct cases of ST elevation on
electrocardiogram occurring in patients with COVID-19 and review important diagnostic and management considerations for
the front-line clinician.
